Safety & Recalls

Latest News

June 29th 2021
FDA Approves Safety Updates to Synjardy Label

The label for the type 2 diabetes treatment has been updated to include the risk of ketoacidosis and damage to the kidney.

June 24th 2021

Bayer Introduces Updated Packaging for Stivarga

June 16th 2021

Reducing Cardiac Toxicity During Cancer Treatment

June 16th 2021

ASCO Abstracts Focus on Adverse Events of Checkpoint Inhibitors